University Health Network
🇨🇦Canada
Canadian Adult Congenital Heart Disease Intervention Registry
Not yet recruiting
- Conditions
- Coarctation of AortaTransposition of Great VesselsAtrial Septal DefectPatent Foramen OvaleFontanPercutaneous Pulmonary Valve ImplantationTetralogy of Fallot
- Interventions
- Other: Participants undergoing ACHD intervention
- First Posted Date
- 2020-02-28
- Last Posted Date
- 2020-02-28
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 9000
- Registration Number
- NCT04288596
- Locations
- 🇨🇦
Toronto General Hospital, Toronto, Ontario, Canada
Cell-free DNA in Hereditary And High-Risk Malignancies
Active, not recruiting
- Conditions
- Hereditary Cancer Syndrome
- Interventions
- Genetic: Next generation sequencing (NGS)
- First Posted Date
- 2020-02-10
- Last Posted Date
- 2024-10-28
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 1416
- Registration Number
- NCT04261972
- Locations
- 🇨🇦
BC Cancer Agency, Vancouver, British Columbia, Canada
🇨🇦Sinai Health System, Toronto, Ontario, Canada
🇨🇦IWK Health Centre, Halifax, Nova Scotia, Canada
A Phase 2 Study of Durvalumab (MEDI4736) and Oleclumab (MEDI9447) in Multi-Cancer Populations With Correlation to Clinical, Molecular and Immunologic Parameters With DNA MethylaTION
Phase 2
Withdrawn
- Conditions
- Non Small Cell Lung CancerRenal Cell Carcinoma
- Interventions
- Biological: DurvalumabBiological: Oleclumab
- First Posted Date
- 2020-02-10
- Last Posted Date
- 2020-11-17
- Lead Sponsor
- University Health Network, Toronto
- Registration Number
- NCT04262375
- Locations
- 🇨🇦
Princess Margaret Cancer Centre, Toronto, Ontario, Canada
Restoring Upright Mobility After Spinal Cord Injury
Not Applicable
Completed
- Conditions
- Spinal Cord DiseasesSpinal Cord Injuries
- First Posted Date
- 2020-02-10
- Last Posted Date
- 2023-05-23
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 5
- Registration Number
- NCT04262414
- Locations
- 🇨🇦
Lyndhurst Centre, Toronto Rehabilitation Institute-UHN, Toronto, Ontario, Canada
A Multi-Cancer, Multi-State, Platform Study of Durvalumab (MEDI4736) and Oleclumab (MEDI9447) in Pancreatic Adenocarcinoma, Non-Small Cell Lung Cancer and Squamous Cell Carcinoma of the Head and Neck to Correlate Clinical, Molecular and Immunologic Parameters With DNA Methylation
Phase 2
Withdrawn
- Conditions
- Pancreatic Ductal AdenocarcinomaNon-small Cell Lung CancerSquamous Cell Carcinoma of Head and Neck
- Interventions
- Biological: DurvalumabBiological: Oleclumab
- First Posted Date
- 2020-02-10
- Last Posted Date
- 2020-11-17
- Lead Sponsor
- University Health Network, Toronto
- Registration Number
- NCT04262388
- Locations
- 🇨🇦
Princess Margaret Cancer Centre, Toronto, Ontario, Canada
DAPAgliflozin Sodium Water glucosE EffecTs in Patients at High Cardiovascular Risk
Phase 2
Recruiting
- Conditions
- Cardiovascular Risk Factor
- Interventions
- Drug: Placebo oral tablet
- First Posted Date
- 2020-02-06
- Last Posted Date
- 2023-05-17
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 50
- Registration Number
- NCT04258371
- Locations
- 🇨🇦
Renal Physiology Laboratory, Toronto, Canada
Prehabilitation to Improve Cancer Surgery Outcomes in AYA Patients With Extremity Sarcomas
Not Applicable
Completed
- Conditions
- OsteosarcomaSarcoma,Soft Tissue
- Interventions
- Behavioral: Multimodal prehabilitation
- First Posted Date
- 2020-01-30
- Last Posted Date
- 2023-12-27
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 7
- Registration Number
- NCT04248959
- Locations
- 🇨🇦
University Health Network, Toronto, Ontario, Canada
Immune Resistance Interrogation Study
Recruiting
- Conditions
- Solid TumorMetastatic CancerImmune ResistanceCancer
- First Posted Date
- 2020-01-28
- Last Posted Date
- 2024-03-12
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 100
- Registration Number
- NCT04243720
- Locations
- 🇨🇦
Princess Margaret Cancer Centre, Toronto, Ontario, Canada
FLT-PET / MRI Brain Mets
Recruiting
- Conditions
- Brain MetastasesRadionecrosis
- First Posted Date
- 2020-01-28
- Last Posted Date
- 2025-01-16
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 30
- Registration Number
- NCT04244019
- Locations
- 🇨🇦
University Health Network, Toronto, Ontario, Canada
Trials of Ventilation Assisted Substance Elimination Via the Lung - Ethanol (VASEL - Ethanol)
Not Applicable
- Conditions
- Alcohol Intoxication
- Interventions
- Device: ClearMateTM
- First Posted Date
- 2020-01-18
- Last Posted Date
- 2020-01-18
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 40
- Registration Number
- NCT04229732
© Copyright 2025. All Rights Reserved by MedPath